I agree. I just bought today at 80.57 and consider it a good price. Their pipeline is better than Amgen's without the lastest problem amgen has with it's anemia drug. DNA just got expanded approval for Herceptin. Zack's has DNA as one of their four top recommendations. Goldman rates it a buy with $95 as a low price target. Wish I'd bought it when it went down to 30! Cie la vie.
Best Of |
Favorites & Replies |
Start a New Board |
My Fool |
BATS data provided in real-time. NYSE, NASDAQ and NYSEMKT data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates, Analyst Rat